SARS-CoV-2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals

SA Chen, E Arutyunova, J Lu, MB Khan… - ACS Central …, 2023 - ACS Publications
The main protease of SARS-CoV-2 (Mpro) is the most promising drug target against
coronaviruses due to its essential role in virus replication. With newly emerging variants …

Understanding protein domain-swapping using structure-based models of protein folding

NM Mascarenhas, S Gosavi - Progress in biophysics and molecular biology, 2017 - Elsevier
In domain-swapping, two or more identical protein monomers exchange structural elements
and fold into dimers or multimers whose units are structurally similar to the original …

A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening

C Gorgulla, KMP Das, KE Leigh, M Cespugli… - Iscience, 2021 - cell.com
The unparalleled global effort to combat the continuing severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pandemic over the last year has resulted in promising …

Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of …

X Deng, SE StJohn, HL Osswald, A O'Brien… - Journal of …, 2014 - Am Soc Microbiol
Viral protease inhibitors are remarkably effective at blocking the replication of viruses such
as human immunodeficiency virus and hepatitis C virus, but they inevitably lead to the …

Characterization of alternate encounter assemblies of SARS-CoV-2 main protease

A Aniana, NT Nashed, R Ghirlando, VN Drago… - Journal of Biological …, 2024 - jbc.org
The assembly of two monomeric constructs spanning segments 1-199 (MPro 1-199) and 10-
306 (MPro 10-306) of SARS-CoV-2 main protease (MPro) was examined to assess the …

Repurposing low-molecular-weight drugs against the main protease of severe acute respiratory syndrome coronavirus 2

J Gao, L Zhang, X Liu, F Li, R Ma, Z Zhu… - The Journal of …, 2020 - ACS Publications
The coronavirus disease pandemic caused by infection with the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected the global healthcare system. As low …

An isothermal calorimetry assay for determining steady state kinetic and Ensitrelvir inhibition parameters for SARS-CoV-2 3CL-protease

L Mazzei, S Ranieri, D Silvestri, R Greene-Cramer… - Scientific Reports, 2024 - nature.com
This manuscript details the application of Isothermal Titration Calorimetry (ITC) to
characterize the kinetics of 3CLpro, the main protease from the Severe Acute Respiratory …

Domain-swapped cytochrome cb 562 dimer and its nanocage encapsulating a Zn–SO 4 cluster in the internal cavity

T Miyamoto, M Kuribayashi, S Nagao, Y Shomura… - Chemical …, 2015 - pubs.rsc.org
Protein nanostructures have been gaining in interest, along with developments in new
methods for construction of novel nanostructures. We have previously shown that c-type …

Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease

D Deodato, N Asad, TM Dore - Bioorganic & Medicinal Chemistry Letters, 2022 - Elsevier
The discovery of antiviral agents against SARS-CoV-2 is an important step toward ending
the COVID-19 pandemic and to tackle future outbreaks. In this context, the main protease (M …

The protonation state of an evolutionarily conserved histidine modulates domain swapping stability of FoxP1

E Medina, P Villalobos, R Coñuecar… - Scientific reports, 2019 - nature.com
Forkhead box P (FoxP) proteins are members of the versatile Fox transcription factors, which
control the timing and expression of multiple genes for eukaryotic cell homeostasis …